Javier B. Szwarcberg - 14 Mar 2024 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Samir Gharib, Attorney-in-Fact
Issuer symbol
SPRB
Transactions as of
14 Mar 2024
Net transactions value
$0
Form type
4
Filing time
18 Mar 2024, 16:27:29 UTC
Previous filing
18 Dec 2023
Next filing
20 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRB Restricted Stock Units Award $0 +358,800 $0.000000 358,800 14 Mar 2024 Common Stock 358,800 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of SPRB common stock.
F2 Subject to the Reporting Person's Continuous Service as of each such vesting date, 25% of the total number of RSUs vests upon each of the first, second, third and fourth anniversaries of the achievement of a specified clinical development objective.